aluates Reports

$ 0.0

Automative

Global Drugs for Herpes Labialis (Oral Herpes) Market Research Report 2026

Published Date: 2026-02-10

Report Code: QYRE-Auto-11136

Global Drugs for Herpes Labialis Oral Herpes Market Insights and Forecast to 2028

BUY CHAPTERS

Global Drugs for Herpes Labialis (Oral Herpes) Market Research Report 2026

Code: QYRE-Auto-11136

Report

2026-02-10

Pages:125

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GSK

Novartis

TEVA

Mylan NV

Cadila

Apotex

Daewoong Pharmaceutical

LIVZON

Luoxin

Med shine

Bayer (Campho Phenique)

Blistex

Hikma

Haiwang

Carmex

Cipher

KELUN

Drugs for Herpes Labialis (Oral Herpes) Market Size

The global Drugs for Herpes Labialis (Oral Herpes) market was valued at US$ 2822 million in 2025 and is anticipated to reach US$ 3926 million by 2032, at a CAGR of 4.9% from 2026 to 2032.

Drugs for Herpes Labialis (Oral Herpes) Market

Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.

Global Drugs for Herpes Labialis (Oral Herpes) key players include GSK, Novartis, Teva, Mylan, Cadila, etc. Global top five manufacturers hold a share about 55%. North America is the largest market, with a share about 35%, followed by Europe, with a share about 30 percent. In terms of product, Rx Drugs is the largest segment, with a share about 90%. And in terms of application, the largest application is Oral, followed by External Use, and Injection, etc.

This report delivers a comprehensive overview of the global Drugs for Herpes Labialis (Oral Herpes) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drugs for Herpes Labialis (Oral Herpes). The Drugs for Herpes Labialis (Oral Herpes) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Drugs for Herpes Labialis (Oral Herpes) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Drugs for Herpes Labialis (Oral Herpes) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Drugs for Herpes Labialis (Oral Herpes) Market Report

Report Metric	Details
Report Name	Drugs for Herpes Labialis (Oral Herpes) Market
Accounted market size in 2025	US$ 2822 million
Forecasted market size in 2032	US$ 3926 million
CAGR	4.9%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Aciclovir Valacyclovir Famciclovir Docosanol Other
Segment by Application	External Use Oral Injection
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Novartis, Teva, Mylan, Cadila, Apotex, Daewoong Pharmaceutical, Livzon, Luoxin, Med shine, Bayer (Campho Phenique), Blistex, Kelun, Hikma, Haiwang, Carmex, Cipher
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Drugs for Herpes Labialis (Oral Herpes) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Drugs for Herpes Labialis (Oral Herpes) Market growing?

Ans: The Drugs for Herpes Labialis (Oral Herpes) Market witnessing a CAGR of 4.9% during the forecast period 2026-2032.

What is the Drugs for Herpes Labialis (Oral Herpes) Market size in 2032?

Ans: The Drugs for Herpes Labialis (Oral Herpes) Market size in 2032 will be US$ 3926 million.

What is the market share of major companies in Drugs for Herpes Labialis (Oral Herpes) Market?

Ans: Global top five manufacturers hold a share about 55%.

Who are the main players in the Drugs for Herpes Labialis (Oral Herpes) Market report?

Ans: The main players in the Drugs for Herpes Labialis (Oral Herpes) Market are GSK, Novartis, Teva, Mylan, Cadila, Apotex, Daewoong Pharmaceutical, Livzon, Luoxin, Med shine, Bayer (Campho Phenique), Blistex, Kelun, Hikma, Haiwang, Carmex, Cipher

What are the Application segmentation covered in the Drugs for Herpes Labialis (Oral Herpes) Market report?

Ans: The Applications covered in the Drugs for Herpes Labialis (Oral Herpes) Market report are External Use, Oral, Injection

What are the Type segmentation covered in the Drugs for Herpes Labialis (Oral Herpes) Market report?

Ans: The Types covered in the Drugs for Herpes Labialis (Oral Herpes) Market report are Aciclovir, Valacyclovir, Famciclovir, Docosanol, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Aciclovir

1.2.3 Valacyclovir

1.2.4 Famciclovir

1.2.5 Docosanol

1.2.6 Other

1.3 Market by Application

1.3.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 External Use

1.3.3 Oral

1.3.4 Injection

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Perspective (2021–2032)

2.2 Global Drugs for Herpes Labialis (Oral Herpes) Growth Trends by Region

2.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Region (2021–2026)

2.2.3 Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Region (2027–2032)

2.3 Drugs for Herpes Labialis (Oral Herpes) Market Dynamics

2.3.1 Drugs for Herpes Labialis (Oral Herpes) Industry Trends

2.3.2 Drugs for Herpes Labialis (Oral Herpes) Market Drivers

2.3.3 Drugs for Herpes Labialis (Oral Herpes) Market Challenges

2.3.4 Drugs for Herpes Labialis (Oral Herpes) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Revenue

3.1.1 Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Revenue (2021–2026)

3.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Players (2021–2026)

3.2 Global Top Drugs for Herpes Labialis (Oral Herpes) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Drugs for Herpes Labialis (Oral Herpes) Revenue

3.4 Global Drugs for Herpes Labialis (Oral Herpes) Market Concentration Ratio

3.4.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drugs for Herpes Labialis (Oral Herpes) Revenue in 2025

3.5 Global Key Players of Drugs for Herpes Labialis (Oral Herpes) Head Offices and Areas Served

3.6 Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Products and Applications

3.7 Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Drugs for Herpes Labialis (Oral Herpes) Breakdown Data by Type

4.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Type (2021–2026)

4.2 Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Type (2027–2032)

5 Drugs for Herpes Labialis (Oral Herpes) Breakdown Data by Application

5.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Application (2021–2026)

5.2 Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size (2021–2032)

6.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2021–2026)

6.4 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size (2021–2032)

7.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2021–2026)

7.4 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size (2021–2032)

8.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2021–2026)

8.4 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size (2021–2032)

9.2 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2021–2026)

9.4 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size (2021–2032)

10.2 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2021–2026)

10.4 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Details

11.1.2 GSK Business Overview

11.1.3 GSK Drugs for Herpes Labialis (Oral Herpes) Introduction

11.1.4 GSK Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

11.1.5 GSK Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Introduction

11.2.4 Novartis Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

11.2.5 Novartis Recent Development

11.3 Teva

11.3.1 Teva Company Details

11.3.2 Teva Business Overview

11.3.3 Teva Drugs for Herpes Labialis (Oral Herpes) Introduction

11.3.4 Teva Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

11.3.5 Teva Recent Development

11.4 Mylan

11.4.1 Mylan Company Details

11.4.2 Mylan Business Overview

11.4.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Introduction

11.4.4 Mylan Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

11.4.5 Mylan Recent Development

11.5 Cadila

11.5.1 Cadila Company Details

11.5.2 Cadila Business Overview

11.5.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Introduction

11.5.4 Cadila Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

11.5.5 Cadila Recent Development

11.6 Apotex

11.6.1 Apotex Company Details

11.6.2 Apotex Business Overview

11.6.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Introduction

11.6.4 Apotex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

11.6.5 Apotex Recent Development

11.7 Daewoong Pharmaceutical

11.7.1 Daewoong Pharmaceutical Company Details

11.7.2 Daewoong Pharmaceutical Business Overview

11.7.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Introduction

11.7.4 Daewoong Pharmaceutical Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

11.7.5 Daewoong Pharmaceutical Recent Development

11.8 Livzon

11.8.1 Livzon Company Details

11.8.2 Livzon Business Overview

11.8.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Introduction

11.8.4 Livzon Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

11.8.5 Livzon Recent Development

11.9 Luoxin

11.9.1 Luoxin Company Details

11.9.2 Luoxin Business Overview

11.9.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Introduction

11.9.4 Luoxin Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

11.9.5 Luoxin Recent Development

11.10 Med shine

11.10.1 Med shine Company Details

11.10.2 Med shine Business Overview

11.10.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Introduction

11.10.4 Med shine Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

11.10.5 Med shine Recent Development

11.11 Bayer (Campho Phenique)

11.11.1 Bayer (Campho Phenique) Company Details

11.11.2 Bayer (Campho Phenique) Business Overview

11.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Introduction

11.11.4 Bayer (Campho Phenique) Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

11.11.5 Bayer (Campho Phenique) Recent Development

11.12 Blistex

11.12.1 Blistex Company Details

11.12.2 Blistex Business Overview

11.12.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Introduction

11.12.4 Blistex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

11.12.5 Blistex Recent Development

11.13 Kelun

11.13.1 Kelun Company Details

11.13.2 Kelun Business Overview

11.13.3 Kelun Drugs for Herpes Labialis (Oral Herpes) Introduction

11.13.4 Kelun Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

11.13.5 Kelun Recent Development

11.14 Hikma

11.14.1 Hikma Company Details

11.14.2 Hikma Business Overview

11.14.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Introduction

11.14.4 Hikma Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

11.14.5 Hikma Recent Development

11.15 Haiwang

11.15.1 Haiwang Company Details

11.15.2 Haiwang Business Overview

11.15.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Introduction

11.15.4 Haiwang Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

11.15.5 Haiwang Recent Development

11.16 Carmex

11.16.1 Carmex Company Details

11.16.2 Carmex Business Overview

11.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Introduction

11.16.4 Carmex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

11.16.5 Carmex Recent Development

11.17 Cipher

11.17.1 Cipher Company Details

11.17.2 Cipher Business Overview

11.17.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Introduction

11.17.4 Cipher Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

11.17.5 Cipher Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GSK

Novartis

TEVA

Mylan NV

Cadila

Apotex

Daewoong Pharmaceutical

LIVZON

Luoxin

Med shine

Bayer (Campho Phenique)

Blistex

Hikma

Haiwang

Carmex

Cipher

KELUN

List of Tables

Table 1. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Aciclovir

Table 3. Key Players of Valacyclovir

Table 4. Key Players of Famciclovir

Table 5. Key Players of Docosanol

Table 6. Key Players of Other

Table 7. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (US$ Million), 2021–2026

Table 10. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2021–2026)

Table 11. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Region (US$ Million), 2027–2032

Table 12. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2027–2032)

Table 13. Drugs for Herpes Labialis (Oral Herpes) Market Trends

Table 14. Drugs for Herpes Labialis (Oral Herpes) Market Drivers

Table 15. Drugs for Herpes Labialis (Oral Herpes) Market Challenges

Table 16. Drugs for Herpes Labialis (Oral Herpes) Market Restraints

Table 17. Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Players (US$ Million), 2021–2026

Table 18. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Players (2021–2026)

Table 19. Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Drugs for Herpes Labialis (Oral Herpes) Revenue, 2025

Table 20. Ranking of Global Top Drugs for Herpes Labialis (Oral Herpes) Companies by Revenue (US$ Million) in 2025

Table 21. Global 5 Largest Players Market Share by Drugs for Herpes Labialis (Oral Herpes) Revenue (CR5 and HHI), 2021–2026

Table 22. Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Headquarters and Area Served

Table 23. Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Products and Applications

Table 24. Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Date of General Availability (GA)

Table 25. Mergers and Acquisitions, Expansion Plans

Table 26. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (US$ Million), 2021–2026

Table 27. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2021–2026)

Table 28. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Type (US$ Million), 2027–2032

Table 29. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2027–2032)

Table 30. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (US$ Million), 2021–2026

Table 31. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Application (2021–2026)

Table 32. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Application (US$ Million), 2027–2032

Table 33. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Application (2027–2032)

Table 34. North America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (US$ Million), 2021–2026

Table 36. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (US$ Million), 2027–2032

Table 37. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 38. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (US$ Million), 2021–2026

Table 39. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (US$ Million), 2027–2032

Table 40. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 41. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (US$ Million), 2021–2026

Table 42. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (US$ Million), 2027–2032

Table 43. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (US$ Million), 2021–2026

Table 45. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (US$ Million), 2027–2032

Table 46. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (US$ Million), 2021–2026

Table 48. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (US$ Million), 2027–2032

Table 49. GSK Company Details

Table 50. GSK Business Overview

Table 51. GSK Drugs for Herpes Labialis (Oral Herpes) Product

Table 52. GSK Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (US$ Million), 2021–2026

Table 53. GSK Recent Development

Table 54. Novartis Company Details

Table 55. Novartis Business Overview

Table 56. Novartis Drugs for Herpes Labialis (Oral Herpes) Product

Table 57. Novartis Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (US$ Million), 2021–2026

Table 58. Novartis Recent Development

Table 59. Teva Company Details

Table 60. Teva Business Overview

Table 61. Teva Drugs for Herpes Labialis (Oral Herpes) Product

Table 62. Teva Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (US$ Million), 2021–2026

Table 63. Teva Recent Development

Table 64. Mylan Company Details

Table 65. Mylan Business Overview

Table 66. Mylan Drugs for Herpes Labialis (Oral Herpes) Product

Table 67. Mylan Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (US$ Million), 2021–2026

Table 68. Mylan Recent Development

Table 69. Cadila Company Details

Table 70. Cadila Business Overview

Table 71. Cadila Drugs for Herpes Labialis (Oral Herpes) Product

Table 72. Cadila Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (US$ Million), 2021–2026

Table 73. Cadila Recent Development

Table 74. Apotex Company Details

Table 75. Apotex Business Overview

Table 76. Apotex Drugs for Herpes Labialis (Oral Herpes) Product

Table 77. Apotex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (US$ Million), 2021–2026

Table 78. Apotex Recent Development

Table 79. Daewoong Pharmaceutical Company Details

Table 80. Daewoong Pharmaceutical Business Overview

Table 81. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product

Table 82. Daewoong Pharmaceutical Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (US$ Million), 2021–2026

Table 83. Daewoong Pharmaceutical Recent Development

Table 84. Livzon Company Details

Table 85. Livzon Business Overview

Table 86. Livzon Drugs for Herpes Labialis (Oral Herpes) Product

Table 87. Livzon Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (US$ Million), 2021–2026

Table 88. Livzon Recent Development

Table 89. Luoxin Company Details

Table 90. Luoxin Business Overview

Table 91. Luoxin Drugs for Herpes Labialis (Oral Herpes) Product

Table 92. Luoxin Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (US$ Million), 2021–2026

Table 93. Luoxin Recent Development

Table 94. Med shine Company Details

Table 95. Med shine Business Overview

Table 96. Med shine Drugs for Herpes Labialis (Oral Herpes) Product

Table 97. Med shine Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (US$ Million), 2021–2026

Table 98. Med shine Recent Development

Table 99. Bayer (Campho Phenique) Company Details

Table 100. Bayer (Campho Phenique) Business Overview

Table 101. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product

Table 102. Bayer (Campho Phenique) Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (US$ Million), 2021–2026

Table 103. Bayer (Campho Phenique) Recent Development

Table 104. Blistex Company Details

Table 105. Blistex Business Overview

Table 106. Blistex Drugs for Herpes Labialis (Oral Herpes) Product

Table 107. Blistex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (US$ Million), 2021–2026

Table 108. Blistex Recent Development

Table 109. Kelun Company Details

Table 110. Kelun Business Overview

Table 111. Kelun Drugs for Herpes Labialis (Oral Herpes) Product

Table 112. Kelun Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (US$ Million), 2021–2026

Table 113. Kelun Recent Development

Table 114. Hikma Company Details

Table 115. Hikma Business Overview

Table 116. Hikma Drugs for Herpes Labialis (Oral Herpes) Product

Table 117. Hikma Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (US$ Million), 2021–2026

Table 118. Hikma Recent Development

Table 119. Haiwang Company Details

Table 120. Haiwang Business Overview

Table 121. Haiwang Drugs for Herpes Labialis (Oral Herpes) Product

Table 122. Haiwang Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (US$ Million), 2021–2026

Table 123. Haiwang Recent Development

Table 124. Carmex Company Details

Table 125. Carmex Business Overview

Table 126. Carmex Drugs for Herpes Labialis (Oral Herpes) Product

Table 127. Carmex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (US$ Million), 2021–2026

Table 128. Carmex Recent Development

Table 129. Cipher Company Details

Table 130. Cipher Business Overview

Table 131. Cipher Drugs for Herpes Labialis (Oral Herpes) Product

Table 132. Cipher Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (US$ Million), 2021–2026

Table 133. Cipher Recent Development

Table 134. Research Programs/Design for This Report

Table 135. Key Data Information from Secondary Sources

Table 136. Key Data Information from Primary Sources

Table 137. Authors List of This Report

List of Figures

Figure 1. Drugs for Herpes Labialis (Oral Herpes) Picture

Figure 2. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Type: 2025 vs 2032

Figure 4. Aciclovir Features

Figure 5. Valacyclovir Features

Figure 6. Famciclovir Features

Figure 7. Docosanol Features

Figure 8. Other Features

Figure 9. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (US$ Million), 2021–2032

Figure 10. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Application: 2025 vs 2032

Figure 11. External Use Case Studies

Figure 12. Oral Case Studies

Figure 13. Injection Case Studies

Figure 14. Drugs for Herpes Labialis (Oral Herpes) Report Years Considered

Figure 15. Global Drugs for Herpes Labialis (Oral Herpes) Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 16. Global Drugs for Herpes Labialis (Oral Herpes) Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Region: 2025 vs 2032

Figure 18. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Players in 2025

Figure 19. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by Drugs for Herpes Labialis (Oral Herpes) Revenue in 2025

Figure 21. North America Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2021–2032)

Figure 23. United States Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Canada Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2021–2032)

Figure 27. Germany Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. France Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. U.K. Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Italy Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Russia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Ireland Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Share by Region (2021–2032)

Figure 35. China Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Japan Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. South Korea Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. India Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Australia & New Zealand Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2021–2032)

Figure 43. Mexico Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Brazil Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Share by Country (2021–2032)

Figure 47. Israel Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Saudi Arabia Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. UAE Drugs for Herpes Labialis (Oral Herpes) Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. GSK Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

Figure 51. Novartis Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

Figure 52. Teva Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

Figure 53. Mylan Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

Figure 54. Cadila Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

Figure 55. Apotex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

Figure 56. Daewoong Pharmaceutical Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

Figure 57. Livzon Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

Figure 58. Luoxin Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

Figure 59. Med shine Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

Figure 60. Bayer (Campho Phenique) Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

Figure 61. Blistex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

Figure 62. Kelun Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

Figure 63. Hikma Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

Figure 64. Haiwang Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

Figure 65. Carmex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

Figure 66. Cipher Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2021–2026)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Herpes Labialis Treatment Market Research Report 2024

Global Genital Herpes Treatment Drugs Market Insights Forecast to 2030

Herpes Simplex Virus Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Herpes Simplex Virus HSV Vaccines Market Insights Forecast to 2030

Global Herpes Simplex Keratitis Drug Market Insights Forecast to 2030

Herpes Simplex Keratitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Herpes Infection Treatment Market Research Report 2025

Global Mouth Ulcer Treatment Drug Market Insights Forecast to 2030

Global Herpes Zoster Ophthalmicus Drug Market Insights Forecast to 2030

Global Genital Herpes Treatment Market Research Report 2024

Global Genital Herpes Treatment Drug Market Research Report 2025

Genital Herpes Research and Development Pipeline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharyngitis Drug Market Research Report 2025

Global Mouth Ulcers Treatment Market Insights Forecast to 2030

Mouth Ulcers Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Xerostomia Dry Mouth Disease Therapeutics Market Insights Forecast to 2030

Angular Cheilitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Herpersvirus 5 HHV 5 Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gingivitis Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions